Connection
Jennifer Laudadio to Piperazines
This is a "connection" page, showing publications Jennifer Laudadio has written about Piperazines.
|
|
Connection Strength |
|
|
|
|
|
0.098 |
|
|
|
-
Press RD, Willis SG, Laudadio J, Mauro MJ, Deininger MW. Determining the rise in BCR-ABL RNA that optimally predicts a kinase domain mutation in patients with chronic myeloid leukemia on imatinib. Blood. 2009 Sep 24; 114(13):2598-605.
Score: 0.079
-
Quigley NB, Henley DC, Hubbard RA, Laudadio J, Press RD. ABL kinase domain pseudoexon insertion is not uncommon in BCR-ABL transcripts. J Mol Diagn. 2008 Sep; 10(5):475-6; author reply 476.
Score: 0.019